Compared to normal tissues, MYH11 is markedly downregulated in CRC tissues, and its overexpression significantly inhibits CRC cell proliferation, migration, and invasion by downregulating EMT markers and targeting ZEB1, a key promoter of malignant cell behavior. Here, ZEB1 is linked to colorectal carcinoma.